Related Experiment Videos
[Recombinant allergens: diagnostic use and therapeutic perspectives]
1Service de Pneumologie, Hôpitaux Universitaires de Strasbourg.
Revue Des Maladies Respiratoires
|July 21, 2000
Summary
Recombinant allergens, produced using genetic engineering, are validated for accurate allergy diagnosis. These tools aid in understanding IgE responses and developing new immunotherapies for allergic diseases.
Area of Science:
- Allergen immunotherapy
- Molecular allergology
- Genetic engineering
Context:
- Recombinant allergens are produced using genetic engineering techniques.
- Validation involves in vitro and in vivo testing on allergic subjects.
- Current research focuses on major allergens from pollens, mites, and domestic sources.
Purpose:
- To validate the immunological activity and identity of recombinant allergens.
- To assess the diagnostic potential of recombinant allergens for various allergic conditions.
- To explore the use of modified recombinant allergens for future immunotherapy.
Summary:
- Recombinant allergens like BeTv1, phleole allergens, and mite group 2 allergens have shown significant diagnostic utility.
- Blot5, Bla g 4/5, and Asp f 1 demonstrate effectiveness in detecting sensitization to specific environmental and domestic allergens.
- Studies on animal allergens (Equ c 1, Bos d 2) are also progressing.
Impact:
- Recombinant allergens enable standardized diagnostic tests and better understanding of IgE specificities.
- They facilitate the quantification of specific IgE and improve the approach to mixed allergies.
- Modified recombinant allergens offer promising avenues for novel specific immunotherapy strategies.